NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America
11 juin 2024 08h40 HE
|
NEXGEL, INC.
LANGHORNE, Pa., June 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle,...
NEXGEL and Partners for World Health Join Forces to Support Humanitarian Relief Efforts in Ukraine and Around the World
06 juil. 2022 07h30 HE
|
NEXGEL, INC.
For Every Two Boxes of SilverSeal® Purchased, One is Donated to Those Suffering in Ukraine LANGHORNE, Pa., July 06, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the...